Mayne Pharma Group Ltd (MYX)

Currency in AUD
2.890
0.000(0.00%)
Closed·
MYX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.8502.960
52 wk Range
2.8007.310
Key Statistics
Bid/Ask
2.86 / 2.92
Prev. Close
2.89
Open
2.86
Day's Range
2.85-2.96
52 wk Range
2.8-7.31
Volume
434.12K
Average Volume (3m)
552.39K
1-Year Change
-36.4835%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MYX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.100
Upside
+111.07%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low revenue valuation multiple

Mayne Pharma Group Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Mayne Pharma Group Ltd Company Profile

Mayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women’s health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. It operates through three segments: Women’s Health, Dermatology, and International. The company provides oral drug delivery systems, as well as contract development and manufacturing services to third-party customers. It also distributes specialty pharmaceutical products in the dermatology, women’s health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Employees
491
Market
Australia

Compare MYX to Peers and Sector

Metrics to compare
MYX
Peers
Sector
Relationship
P/E Ratio
−2.6x13.3x−0.6x
PEG Ratio
−0.060.060.00
Price/Book
0.6x4.5x2.6x
Price / LTM Sales
0.6x4.9x3.4x
Upside (Analyst Target)
111.1%79.8%42.0%
Fair Value Upside
Unlock17.7%5.8%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 6.100
(+111.07% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Canaccord Genuity
Hold7.40+156.06%6.25DowngradeFeb 24, 2025

Earnings

Latest Release
Nov 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

MYX Income Statement

People Also Watch

0.430
CRN
-2.27%
2.38
NUF
-0.83%
26.050
ORI
+0.97%

FAQ

What Is the Mayne Pharma (MYX) Stock Price Today?

The Mayne Pharma stock price today is 2.890

What Stock Exchange Does Mayne Pharma Trade On?

Mayne Pharma is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Mayne Pharma?

The stock symbol for Mayne Pharma is "MYX."

What Is the Mayne Pharma Market Cap?

As of today, Mayne Pharma market cap is 235.21M.

What Is Mayne Pharma's Earnings Per Share (TTM)?

The Mayne Pharma EPS (TTM) is -1.14.

When Is the Next Mayne Pharma Earnings Date?

Mayne Pharma will release its next earnings report on Feb 19, 2026.

From a Technical Analysis Perspective, Is MYX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Mayne Pharma Stock Split?

Mayne Pharma has split 4 times.

How Many Employees Does Mayne Pharma Have?

Mayne Pharma has 491 employees.

What is the current trading status of Mayne Pharma (MYX)?

As of Jan 21, 2026, Mayne Pharma (MYX) is trading at a price of 2.890, with a previous close of 2.890. The stock has fluctuated within a day range of 2.850 to 2.960, while its 52-week range spans from 2.800 to 7.310.

What Is Mayne Pharma (MYX) Price Target According to Analysts?

The average 12-month price target for Mayne Pharma is AUD6.100, with a high estimate of AUD6.1 and a low estimate of AUD6.1. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +111.07% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.